Skip to main content
. 2015 Apr 29;(4):CD008138. doi: 10.1002/14651858.CD008138.pub2
Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Failure to achieve complete resolution 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
1.1 Face only 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Failure to achieve complete resolution (long term) 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Face only 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Decrease in erythema score 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 Face only 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Decrease in erythema score (long term) 1 Mean Difference (IV, Random, 95% CI) Totals not selected
4.1 Face only 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
5 Erythema - Failure to achieve complete resolution 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
5.1 Face only 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Decrease in scaling score 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6.1 Face only 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Decrease in scaling score (long term) 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
7.1 Face only 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Scaling - Failure to achieve complete resolution 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 Face only 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Side effects 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
9.1 Face only 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]